<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Endemic Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) is an extranodal <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> appearing predominantly in the jaw in younger children while <z:e sem="disease" ids="C0000735" disease_type="Neoplastic Process" abbrv="">abdominal tumors</z:e> predominate with increasing age </plain></SENT>
<SENT sid="1" pm="."><plain>Previous studies have identified elevated levels of antibodies to Plasmodium falciparum schizont extracts and Epstein-Barr virus (EBV) <z:mp ids='MP_0001799'>viral</z:mp> capsid antigens (VCA) in endemic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> relative to <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e> exposed controls </plain></SENT>
<SENT sid="2" pm="."><plain>However, these studies have neither determined if there were any differences based on the site of clinical presentation of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> nor examined a broader panel of EBV and P. falciparum antigens </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We used a suspension bead Luminex assay to measure the IgG levels against EBV antigens, VCA, EAd, EBNA-1 and Zta as well as P. falciparum MSP-1, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LSA</z:e>-1, and AMA-1 antigens in children with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> (n = 32) and in population-based age-and sex-matched controls (n = 25) from a <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e> endemic region in Western Kenya with high incidence of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>EBV <z:mp ids='MP_0001799'>viral</z:mp> load in plasma was determined by quantitative PCR </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Relative to healthy controls, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> patients had significantly increased anti-Zta (p = 0.0017) and VCA IgG levels (p &lt; 0.0001) and plasma EBV <z:mp ids='MP_0001799'>viral</z:mp> loads (p &lt; 0.0001) </plain></SENT>
<SENT sid="6" pm="."><plain>In contrast, comparable IgG levels to <z:hpo ids='HP_0000001'>all</z:hpo> P. falciparum antigens tested were observed in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> patients compared to controls </plain></SENT>
<SENT sid="7" pm="."><plain>Interestingly, when we grouped <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> patients into those presenting with <z:e sem="disease" ids="C0000735" disease_type="Neoplastic Process" abbrv="">abdominal tumors</z:e> or with jaw <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, we observed significantly higher levels of anti-Zta IgG levels (p &lt; 0.0065) and plasma EBV <z:mp ids='MP_0001799'>viral</z:mp> loads (p &lt; 0.033) in patients with <z:e sem="disease" ids="C0000735" disease_type="Neoplastic Process" abbrv="">abdominal tumors</z:e> compared to patients with jaw <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: Elevated antibodies to Zta and elevated plasma EBV <z:mp ids='MP_0001799'>viral</z:mp> load could be relevant biomarkers for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> and could also be used to confirm <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> presenting in the abdominal region </plain></SENT>
</text></document>